The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Microbial Sensitivity Tests

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Microbial Sensitivity Tests

 

High impact information on Microbial Sensitivity Tests

 

Chemical compound and disease context of Microbial Sensitivity Tests

 

Biological context of Microbial Sensitivity Tests

 

Anatomical context of Microbial Sensitivity Tests

 

Associations of Microbial Sensitivity Tests with chemical compounds

 

Gene context of Microbial Sensitivity Tests

 

Analytical, diagnostic and therapeutic context of Microbial Sensitivity Tests

References

  1. National gonorrhea therapy monitoring study: in vitro antibiotic susceptibility and its correlation with treatment results. Jaffe, H.W., Biddle, J.W., Thornsberry, C., Johnson, R.E., Kaufman, R.E., Reynolds, G.H., Wiesner, P.J. N. Engl. J. Med. (1976) [Pubmed]
  2. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole. Yogev, R., Moxon, E.R. J. Clin. Invest. (1982) [Pubmed]
  3. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Khan, W.A., Seas, C., Dhar, U., Salam, M.A., Bennish, M.L. Ann. Intern. Med. (1997) [Pubmed]
  4. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. Xiao, Y., Cai, Y., Bommineni, Y.R., Fernando, S.C., Prakash, O., Gilliland, S.E., Zhang, G. J. Biol. Chem. (2006) [Pubmed]
  5. Resistance to mecillinam produced by the co-operative action of mutations affecting lipopolysaccharide, spoT, and cya or crp genes of Salmonella typhimurium. Antón, D.N. Mol. Microbiol. (1995) [Pubmed]
  6. Rapid evolution of a protein in vitro by DNA shuffling. Stemmer, W.P. Nature (1994) [Pubmed]
  7. Macrolide resistance among invasive Streptococcus pneumoniae isolates. Hyde, T.B., Gay, K., Stephens, D.S., Vugia, D.J., Pass, M., Johnson, S., Barrett, N.L., Schaffner, W., Cieslak, P.R., Maupin, P.S., Zell, E.R., Jorgensen, J.H., Facklam, R.R., Whitney, C.G. JAMA (2001) [Pubmed]
  8. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. Hanberger, H., Garcia-Rodriguez, J.A., Gobernado, M., Goossens, H., Nilsson, L.E., Struelens, M.J. JAMA (1999) [Pubmed]
  9. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Enne, V.I., Livermore, D.M., Stephens, P., Hall, L.M. Lancet (2001) [Pubmed]
  10. Cefmenoxime: in vitro activity. Stamm, J.M. Am. J. Med. (1984) [Pubmed]
  11. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Kaojarern, S., Supmonchai, K., Phuapradit, P., Mokkhavesa, C., Krittiyanunt, S. Clin. Pharmacol. Ther. (1991) [Pubmed]
  12. Rapid method for determining the minimum inhibitory concentration of ampicillin for Haemophilus influenzae. Ryan, R., Tilton, R.C. Antimicrob. Agents Chemother. (1977) [Pubmed]
  13. Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency. English, A.R., Retsema, J.A., Girard, A.E., Schelkly, W., Lynch, J.E. Antimicrob. Agents Chemother. (1984) [Pubmed]
  14. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria. Devlin, H.R., Boskovski, L. Drugs (1988) [Pubmed]
  15. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. McPhee, J.B., Lewenza, S., Hancock, R.E. Mol. Microbiol. (2003) [Pubmed]
  16. Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding. Perry, T.R., Schentag, J.J. Clinical pharmacokinetics. (2001) [Pubmed]
  17. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration. Kaatz, G.W., Seo, S.M., Foster, T.J. Antimicrob. Agents Chemother. (1999) [Pubmed]
  18. Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species. Loeffler, J., Hagmeyer, L., Hebart, H., Henke, N., Schumacher, U., Einsele, H. Clin. Chem. (2000) [Pubmed]
  19. The emergence of Neisseria gonorrhoeae with decreased susceptibility to Azithromycin in Kansas City, Missouri, 1999 to 2000. McLean, C.A., Wang, S.A., Hoff, G.L., Dennis, L.Y., Trees, D.L., Knapp, J.S., Markowitz, L.E., Levine, W.C. Sexually transmitted diseases. (2004) [Pubmed]
  20. Penetration of lomefloxacin into human prostatic tissue. Leroy, A., Humbert, G., Fillastre, J.P., Grise, P. Am. J. Med. (1992) [Pubmed]
  21. Pharmacokinetic profile of loracarbef. DeSante, K.A., Zeckel, M.L. Am. J. Med. (1992) [Pubmed]
  22. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Wallace, R.J., Brown, B.A., Griffith, D.E., Girard, W.M., Murphy, D.T., Onyi, G.O., Steingrube, V.A., Mazurek, G.H. Am. J. Respir. Crit. Care Med. (1994) [Pubmed]
  23. Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Pfister, H.W., Preac-Mursic, V., Wilske, B., Einhäupl, K.M. Arch. Neurol. (1989) [Pubmed]
  24. Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses. Gerding, D.N., Kozak, A.J., Peterson, L.R., Hall, W.H. Antimicrob. Agents Chemother. (1980) [Pubmed]
  25. Therapy of gonorrhea. Comparison of trimethoprim-sulfamethoxazole and ampicillin. Sattler, F.R., Ruskin, J. JAMA (1978) [Pubmed]
  26. Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Mhalu, F.S., Mmari, P.W., Ijumba, J. Lancet (1979) [Pubmed]
  27. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre. Radetsky, M.S., Istre, G.R., Johansen, T.L., Parmelee, S.W., Lauer, B.A., Wiesenthal, A.M., Glode, M.P. Lancet (1981) [Pubmed]
  28. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Brun-Buisson, C., Legrand, P., Philippon, A., Montravers, F., Ansquer, M., Duval, J. Lancet (1987) [Pubmed]
  29. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men. Handsfield, H.H., Murphy, V.L. Lancet (1983) [Pubmed]
  30. The katE gene, which encodes the catalase HPII of Mycobacterium avium. Milano, A., De Rossi, E., Gusberti, L., Heym, B., Marone, P., Riccardi, G. Mol. Microbiol. (1996) [Pubmed]
  31. Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. Moore, L.J., Pridmore, A.C., Dower, S.K., Read, R.C. J. Infect. Dis. (2003) [Pubmed]
  32. Cloning in Escherichia coli of a Bacillus subtilis arginine repressor gene through its ability to confer structural stability on a fragment carrying genes of arginine biosynthesis. Smith, M.C., Mountain, A., Baumberg, S. Mol. Gen. Genet. (1986) [Pubmed]
  33. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates. Giamarellou, H., Voutsinas, D., Xirouchaki, E. Journal of chemotherapy (Florence, Italy) (1992) [Pubmed]
  34. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Wise, R., Andrews, J.M., Bedford, K.A. Antimicrob. Agents Chemother. (1978) [Pubmed]
  35. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. O'Riordan, T., Mathai, E., Tobin, E., McKenna, D., Keane, C., Sweeney, E., O'Morain, C. Gut (1990) [Pubmed]
  36. Bioassay of antibiotics in body fluids from patients receiving cancer chemotherapeutic agents. Wright, D.N., Matsen, J.M. Antimicrob. Agents Chemother. (1980) [Pubmed]
  37. Comparative study of gentamicin release from normal and low viscosity acrylic bone cement. Bunetel, L., Segui, A., Cormier, M., Langlais, F. Clinical pharmacokinetics. (1990) [Pubmed]
  38. Recognition and resistance in TEM beta-lactamase. Wang, X., Minasov, G., Blázquez, J., Caselli, E., Prati, F., Shoichet, B.K. Biochemistry (2003) [Pubmed]
  39. Reliability of the MS-2 system in detecting methicillin-resistant Staphylococcus aureus. Boyce, J.M., White, R.L., Bonner, M.C., Lockwood, W.R. J. Clin. Microbiol. (1982) [Pubmed]
 
WikiGenes - Universities